Caris Life Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CAI and other ETFs, options, and stocks.About CAI
Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects.
CEODavid Dean Halbert
CEODavid Dean Halbert
Employees—
Employees—
HeadquartersIrving, Texas
HeadquartersIrving, Texas
Founded2008
Founded2008
Employees—
Employees—
CAI Key Statistics
Market cap7.21B
Market cap7.21B
Price-Earnings ratio-10.53
Price-Earnings ratio-10.53
Dividend yield—
Dividend yield—
Average volume2.76M
Average volume2.76M
High today—
High today—
Low today—
Low today—
Open price$25.69
Open price$25.69
Volume0.00
Volume0.00
52 Week high$42.50
52 Week high$42.50
52 Week low$21.00
52 Week low$21.00
Stock Snapshot
Caris Life Sciences(CAI) stock is priced at $25.46, giving the company a market capitalization of 7.21B. It carries a P/E multiple of -10.53.
Caris Life Sciences(CAI) stock opened on 2026-01-23 at $25.69. The price climbed to — and dipped to —.
The Caris Life Sciences(CAI)'s current trading volume is 0, compared to an average daily volume of 2.76M.
During the past year, Caris Life Sciences(CAI) stock moved between $21.00 at its lowest and $42.50 at its peak.
During the past year, Caris Life Sciences(CAI) stock moved between $21.00 at its lowest and $42.50 at its peak.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own CAI. This list is generated using Robinhood data, and it’s not a recommendation.